Multiple Roles of Autophagy in the Sorafenib Resistance of Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is the second leading cause of cancer-related death worldwide, and prognosis remains unsatisfactory since the disease is often diagnosed at the advanced stages. Currently, the multikinase inhibitor sorafenib is the only drug approved for the treatment of advanced HCC....
Збережено в:
| Автори: | , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Cell Physiol Biochem Press GmbH & Co KG
2017-11-01
|
| Серія: | Cellular Physiology and Biochemistry |
| Предмети: | |
| Онлайн доступ: | https://www.karger.com/Article/FullText/485285 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|